Results 1 to 10 of about 62,455 (259)

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients [PDF]

Farmacia Hospitalaria, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
María Ángeles González-Fernández , Elena Villamañán , Inmaculada Jiménez-Nácher , Francisco Moreno , Alicia Herrero , Alejandro Balsa   +5 more
doaj   +5 more sources

Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. [PDF]

Arthritis Res Ther
Ramiro S, Proft F, Sengupta R, van Tubergen A, Moltó A, Gensler LS, Kishimoto M, Taieb V, Kavanagh S, Evans S, Navarro-Compán V.   +10 more
europepmc   +2 more sources

Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study

Advances in Rheumatology, 2023
Background The extra-musculoskeletal manifestations (EMMs) such as recurrent acute anterior uveitis (rAAU), psoriasis (Ps), and inflammatory bowel disease (IBD), are related to the Spondyloarthritis (SpA), as well as they are associated with disease ...
Danielle dos Reis Annunciato, Thauana Luiza Oliveira, Vanessa Oliveira Magalhães, Marcelo de Medeiros Pinheiro   +3 more
doaj   +1 more source

Association of Genetic Marker HLA-B27 with Spondyloarthritis In A Tertiary Care Centre In South India

Journal of Pure and Applied Microbiology, 2022
Human leukocyte antigens (HLA) are gene products found in the major histocompatibility complex, aiding in differentiation of “self” from “non-self” antigens, and is crucial for the communication between immune cells of the human body.
T. Jayaprakash, Om Lokesh Muthamilan, K.V. Leela, C. Panchapakesa Rajendran, Arul Raja Murugan, Sujith Ravi   +5 more
doaj   +1 more source

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review

BMC Musculoskeletal Disorders, 2022
Background Optimal treatment of nonradiographic axial spondyloarthritis depends on accurate and timely diagnosis of the underlying disease; however, patients present with common symptoms that, in the absence of radiographic changes, may confound ...
Philip Mease, Atul Deodhar
doaj   +1 more source

Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

Reumatismo, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can show musculoskeletal symptoms such as peripheral arthritis. In rare cases, peripheral arthritis can develop after the resolution of SARS-CoV-2.
G. El Hasbani, A. Jawad, I. Uthman
doaj   +1 more source

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). [PDF]

, 2020
OBJECTIVES: To investigate the efficacy and safety of ixekizumab for up to 52 weeks in two phase 3 studies of patients with active radiographic axial spondyloarthritis (r-axSpA) who were biological disease-modifying antirheumatic drug (bDMARD)-naive ...
Baraliakos, X., Bertram, C.C., Bosch, F. van den, Carlier, H., COAST-V Study Grp, COAST-W Study Grp, Deodhar, A., Dougados, M., Ermann, J., Gallo, G., Gensler, L.S., Heijde, D. van der, Landewe, R., Li, X.Q., Maksymowych, W.P., Sieper, J., Tomita, T., Walsh, J.A., Wei, J.C.C., Zhao, F.Y.   +19 more
core   +3 more sources

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages [PDF]

, 2016
Introduction: The Assessments of SpondyloArthritis international society Health Index (ASAS HI) measures functioning and health in patients with spondyloarthritis (SpA) across 17 aspects of health and 9 environmental factors (EF).
Bautista-Molano, W, Boonen, A, Braun, J, Burgos-Vargas, R, Chiowchanwisawakit, P, Duruoz, T, El-Zorkany, B, Essers, I, Gaydukova, I, Gossec, L, Grazio, S, Gu, J, Géher, P, Khan, MA, Kiltz, U, Kim, TJ, Maksymowych, WP, Marzo-Ortega, H, Navarro-Compán, V, Olivieri, I, Patrikos, D, Pimentel-Santos, FM, Schirmer, M, Van den Bosch, Filip, van der Heijde, D, Weber, U, Zochling, J   +26 more
core   +13 more sources

Causal relationship between spondylarthritis and stroke in a European population: a two sample Mendelian randomization study

Frontiers in Immunology, 2023
BackgroundObservational studies have found an increased risk of stroke in patients with spondyloarthritis, but the results are susceptible to reverse causality and confounders.
Luofei Zhang, Luofei Zhang, Kefu Yu, Jiping Huo, Shenghui Mei, Zhigang Zhao, Zhigang Zhao, Bin Zhu   +7 more
doaj   +1 more source

The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors

Biomedicines, 2023
Spondyloarthritis (SpA) encompasses a group of chronic inflammatory rheumatic diseases with a predilection for the spinal and sacroiliac joints, which include axial spondyloarthritis, psoriatic arthritis, reactive arthritis, arthritis associated with ...
Anna Davydova, Yuliya Kurochkina, Veronika Goncharova, Mariya Vorobyeva, Maksim Korolev   +4 more
doaj   +1 more source